open access

Vol 8, No 2 (2002)
Original papers
Published online: 2002-03-18
Get Citation

Serological markers of Chlamydia pneumoniae infection in patients with cardiovascular disease

Justyna Niedźwiadek, Elżbieta Mazur, Andrzej Wolski, Andrzej Witkowski, Maria Kozioł-Montewka, Jerzy Michalak
Acta Angiologica 2002;8(2):55-64.

open access

Vol 8, No 2 (2002)
Original papers
Published online: 2002-03-18

Abstract

Background. Infection with Chlamydia pneumoniae, a common human respiratory pathogen, has recently been associated with cardiovascular syndromes, such as AAA, myocardial infarction and stroke. According to the literature data, a significantly high percentage of patients with cardiovascular diseases exhibited serological markers of chronic C. pneumoniae infection.
Aim of the study. The aim of our study was to evaluate the frequency of C. pneumoniae infection in CHD, CAD and AAA patients by measuring specific serum IgG, IgM and IgA levels.
Material and methods. 47 patients (8 F, 39 M), mean age 64.4 years, with acute myocardial infarction (AMI) or unstable angina (UA); 17 patients (3 F, 14 M), mean age 66.5 years operated for CAD and 28 patients (5 F, 23 M), mean age 68.5 years operated for AAA participated in the research. 20 control subjects matched for age and sex (4 F, 16 M) without clinical signs and symptoms of cardiovascular and pulmonary disease, took part in our study. Microimmunofluorescence method was applied to evaluate the level of anti-C. pneumoniae IgG, IgA and IgM. Chlamydia pneumoniae micro-IF test (Labsystem) was used. The results were evaluated by means of STATISTICA program and considered statistically significant when p < 0.05.
Results. Serological markers of chronic C. pneumoniae infection were detected in 37/47 (80.9%) CHD patients, in 12/17 (70.6%) CAD patients, in 25/28 (89.3%) AAA patients and in 6/20 (30%) healthy controls. 21/37 (56.8%) CHD, 5/12 (41.7%) CAD and 10/25 (40.0%) AAA patients with serological signs of chronic infection had high titres of specific IgG and IgA, indicating active infection. All CAD and AAA patients with active infection were symptomatic.
Conclusions. Serological signs of chronic C. pneumoniae infection occur statistically more frequently in CHD, CAD and AAA patients in comparison with healthy controls. Active C. pneumoniae infection is associated with symptomatic CAD and AAA.

Abstract

Background. Infection with Chlamydia pneumoniae, a common human respiratory pathogen, has recently been associated with cardiovascular syndromes, such as AAA, myocardial infarction and stroke. According to the literature data, a significantly high percentage of patients with cardiovascular diseases exhibited serological markers of chronic C. pneumoniae infection.
Aim of the study. The aim of our study was to evaluate the frequency of C. pneumoniae infection in CHD, CAD and AAA patients by measuring specific serum IgG, IgM and IgA levels.
Material and methods. 47 patients (8 F, 39 M), mean age 64.4 years, with acute myocardial infarction (AMI) or unstable angina (UA); 17 patients (3 F, 14 M), mean age 66.5 years operated for CAD and 28 patients (5 F, 23 M), mean age 68.5 years operated for AAA participated in the research. 20 control subjects matched for age and sex (4 F, 16 M) without clinical signs and symptoms of cardiovascular and pulmonary disease, took part in our study. Microimmunofluorescence method was applied to evaluate the level of anti-C. pneumoniae IgG, IgA and IgM. Chlamydia pneumoniae micro-IF test (Labsystem) was used. The results were evaluated by means of STATISTICA program and considered statistically significant when p < 0.05.
Results. Serological markers of chronic C. pneumoniae infection were detected in 37/47 (80.9%) CHD patients, in 12/17 (70.6%) CAD patients, in 25/28 (89.3%) AAA patients and in 6/20 (30%) healthy controls. 21/37 (56.8%) CHD, 5/12 (41.7%) CAD and 10/25 (40.0%) AAA patients with serological signs of chronic infection had high titres of specific IgG and IgA, indicating active infection. All CAD and AAA patients with active infection were symptomatic.
Conclusions. Serological signs of chronic C. pneumoniae infection occur statistically more frequently in CHD, CAD and AAA patients in comparison with healthy controls. Active C. pneumoniae infection is associated with symptomatic CAD and AAA.
Get Citation

Keywords

Chlamydia pneumoniae; cardiovascular disease

About this article
Title

Serological markers of Chlamydia pneumoniae infection in patients with cardiovascular disease

Journal

Acta Angiologica

Issue

Vol 8, No 2 (2002)

Pages

55-64

Published online

2002-03-18

Bibliographic record

Acta Angiologica 2002;8(2):55-64.

Keywords

Chlamydia pneumoniae
cardiovascular disease

Authors

Justyna Niedźwiadek
Elżbieta Mazur
Andrzej Wolski
Andrzej Witkowski
Maria Kozioł-Montewka
Jerzy Michalak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl